Pascal Chanu

13PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersEconomic models and forecastingPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 31, 2026
Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology.

|Jul 17, 2025
Disease Modeling and External Model Evaluation Through Clinical Data Sharing Platform for HR+/HER2- Breast Cancer.

Kenta Yoshida, René Bruno, Pascal Chanu

|Jul 15, 2025
Pharmacokinetic and pharmacodynamic modelling of continuous erythropoiesis receptor activator in children: A comprehensive analysis and real-world data validation.

Samer Mouksassi, Franz Schaefer, Bradley A Warady

|Apr 02, 2025
Use of Real-World Claims Data to Assess the Prevalence of Concomitant Medications to Inform Drug-Drug Interaction Risk in Target Patient Populations.

Alice S Tang, Logan Brooks, Denise M Boudreau

|Feb 05, 2025
Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer.

Phyllis Chan, Stephanie N Liu, Nathalie Gosselin

|Sep 27, 2024
A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma.

Chi-Chung Li, Brendan Bender, Justin Wilkins

Pageof 3

Frequent Collaborators

5 joint publications

Mathilde Marchand

5 joint publications

Jin Y Jin

4 joint publications

René Bruno

3 joint publications

Kenta Yoshida